Keyphrases
COVID-19
90%
ARIC Study
66%
Intracranial Atherosclerotic Disease
66%
Intracranial Atherosclerosis
52%
Vessel Wall MRI
50%
Stenosis
48%
Middle Cerebral Artery Stenosis
45%
Health Systems
42%
Mount Sinai
38%
Transcranial Doppler
37%
Adjusted Odds Ratio
35%
Disease Activity Score
33%
MRI Image Enhancement
33%
Hospitalized COVID-19 Patients
33%
Epilepsy
33%
Neuroimaging Findings
33%
Amyloid Deposition
33%
Cerebrovascular Disease
33%
Cystatin C (Cys C)
33%
Coronary Artery Bypass Graft Surgery
33%
Coronavirus Disease (COVID)
33%
Neurological Manifestations
33%
Cerebral Amyloid Angiopathy
33%
Patient Impact
33%
Psychosocial Outcomes
33%
Cognitive Impairment
33%
Delirium
33%
In-hospital Outcomes
33%
Heart Surgery
33%
Supportive Cancer Care
33%
Kidney Disease
33%
Neuropsychiatric Complications
33%
Brain Amyloid
33%
Ventilatory Support
33%
Impact of Cancer
33%
Noninflammatory
33%
Meta-analysis
33%
Intracranial Large Vessel Occlusion
33%
Randomized Trial
33%
Mortality Reduction
33%
Scoring System
33%
Thrombectomy
33%
Positive Predictive Value
33%
Unilateral Stroke
33%
Executive Control
33%
Right Hemisphere
33%
Confidence Interval
32%
Negative Predictive Value
26%
Albumin-to-creatinine Ratio
25%
High-resolution Vessel Wall Imaging
25%
Medicine and Dentistry
COVID-19
100%
Cohort Analysis
72%
Magnetic Resonance Imaging
71%
Stenosis
68%
Diseases
66%
Amyloid Protein
55%
Atherosclerosis
52%
Health System
41%
Odds Ratio
35%
Malignant Neoplasm
33%
Neurologic Finding
33%
Meta-Analysis
33%
Thrombectomy
33%
Large Vessel Occlusion
33%
Vascular Amyloidosis
33%
Nephropathy
33%
Scoring System
33%
Transcranial Doppler
33%
Middle Cerebral Artery Occlusion
33%
Mental Health
27%
Cystatin C
25%
Creatinine
25%
Apoplexy
22%
Logistic Regression Analysis
22%
Standardized Uptake Value
22%
Hospital Mortality
16%
Clinical Trial
16%
Kidney Function
16%
Kidney Injury
16%
Glomerular Filtration Rate
16%
Polyethylene Terephthalate
16%
Comorbidity
15%
Cross Sectional Study
13%
Middle Cerebral Artery
13%
Digital Subtraction Angiography
13%
Mortality Rate
13%
Apolipoprotein E
11%
Charlson Comorbidity Index
9%
Community-Dwelling Older Adults
8%
Urinary System
8%
Cardiovascular Risk
8%
Antithrombotic
8%
Infarction
7%
Brain Disease
7%
Coma
7%
Alzheimer's Disease
5%
Brain Ischemia
5%
Anticoagulant Therapy
5%
Allele
5%
Ataxia
5%
